Scilex Holding SCLX
NASDAQ SCLX
$5.20 -0.17 (-3.17%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scilex Holding (SCLX) Capital Expenditures (2022 - 2026)

Scilex Holding (SCLX) posted Capital Expenditures of $389000.0 for Q2 2026, down 35.7% on a QoQ basis from $605000.0 in Q1 2026.

Analysis

Scilex Holding (SCLX) Capital Expenditures (2022 - 2026) Analysis & Trends

Scilex Holding has reported Capital Expenditures for 5 years, with the latest figure at $389000.0 in Q2 2026.

  • On a quarterly basis, Capital Expenditures changed N/A year-over-year to $389000.0 in Q2 2026; TTM through Jun 2026 was $1.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $133000.0, up 343.33% from the prior year.
  • Capital Expenditures was $389000.0 for Q2 2026 at Scilex Holding, down from $605000.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $605000.0 in Q1 2026, with the low at -$997000.0 in Q1 2023.
  • Average Capital Expenditures over 5 years is $4222.2, with a median of $35000.0 recorded in 2022.
  • The sharpest annual moves came in 2023 and 2024: Capital Expenditures slumped 245.71% in 2023, then surged 103.01% in 2024.
  • Over 5 years, Capital Expenditures stood at $35000.0 in 2022, then plunged by 245.71% to -$51000.0 in 2023, then soared by 158.82% to $30000.0 in 2024, then jumped by 343.33% to $133000.0 in 2025, then jumped by 192.48% to $389000.0 in 2026.
  • The last three Capital Expenditures figures came in at $389000.0 (Q2 2026), $605000.0 (Q1 2026), and $133000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn 1.32 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn 322.00 Mn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn -321.00 Mn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn 533.00 Mn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn -
7 Revolution Medicines 45.00 Bn 45.00 Bn - 2.29 Mn
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn 12.41 Mn
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn 108.00 Mn
10 Scilex Holding 38.06 Mn -76.90 Mn 3.97 Mn 389,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 389,000.00
Mar 31, 2026 605,000.00
Dec 31, 2025 133,000.00
Mar 31, 2024 30,000.00
Dec 31, 2023 -51,000.00
Jun 30, 2023 193,000.00
Mar 31, 2023 -997,000.00
Dec 31, 2022 35,000.00
Sep 30, 2022 -299,000.00